The role of effective albumin in chronic liver disease

The role of effective albumin in chronic liver disease

Effective albumin refers to serum albumin with intact structure and function. In the course of chronic liver disease, some serum albumin loses its functional integrity through different post-translational modifications such as oxidation and glycosylation. Level of effective albumin is lower in patie...

Full description

Saved in:

Bibliographic Details
Main Author:	LIN Jun, LI Zepeng, YU Junying
Format:	Article
Language:	zho
Published:	Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2024-12-01
Series:	Jichu yixue yu linchuang
Subjects:	effective albumin\|liver cirrhosis\|liver failure\|liver cancer
Online Access:	https://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2024-44-12-1707.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Potential of albumin dialysis at terminal liver failure in patients with chronic liver diseases
by: O. E. Nikiforova, et al.
Published: (2010-08-01)

Changes in the Structural and Functional Albumin Properties in Patients with Decompensated Liver Cirrhosis
by: A. A. Turkina, et al.
Published: (2023-06-01)

Structure and Functions of Human Serum Albumin in Normal Conditions and in Patients with Liver Cirrhosis
by: A. A. Turkina, et al.
Published: (2022-12-01)

Hypoalbuminemia is Associated with Higher 90-Day Mortality and Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma and Liver Cirrhosis Receiving Radiotherapy-Based Therapy
by: Hua YY, et al.
Published: (2024-12-01)

Hyperparathyroidism in Patients with End-Stage Chronic Liver Disease (Clinical Observations)
by: A. A. Lavreniuk, et al.
Published: (2024-12-01)

Safety and efficacy of Single-Pass Albumin Dialysis (SPAD), Prometheus, and Molecular Adsorbent Recycling System (MARS) liver haemodialysis vs. Standard Medical Therapy (SMT): meta-analysis and systematic review
by: Eyad Gadour, et al.
Published: (2024-04-01)

Minimum proportion of future liver remnant in safe major hepatopancreatoduodenectomy
by: Kentaro Umemura, et al.
Published: (2025-01-01)

Modified quick-SOFA score: Can it enhance prognostic assessment for hospitalized patients with chronic liver diseases?: Editorial on “Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment”
by: Simone Incicco, et al.
Published: (2024-10-01)

Opioid sparing anesthesia in patients with liver cirrhosis undergoing liver resection: a controlled randomized double-blind study
by: Eman Sayed Ibrahim, et al.
Published: (2025-02-01)

Research progress on pathogenesis of skin pigmentation in chronic liver disease
by: Tianqi Liu, et al.
Published: (2024-12-01)

Low albumin-to-creatinine ratio: a novel predictor of 90-day mortality in hepatocellular carcinoma with liver cirrhosis
by: Kadek Mercu Narapati Pamungkas, et al.
Published: (2024-11-01)

Challenges in the management of alcohol-associated liver disease in Latin America
by: Francisco Idalsoaga, et al.
Published: (2025-01-01)

Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study
by: Jung Hee Kim, et al.
Published: (2025-12-01)

Impact of acute respiratory distress syndrome on outcome in critically ill patients with liver cirrhosis
by: Pischtaz Adel Tariparast, et al.
Published: (2025-02-01)

Effects of l‐carnitine on frailty status in patients with liver cirrhosis: A randomized‐controlled trial
by: Nasrin Motazedian, et al.
Published: (2024-11-01)

Correlation of the FIB-4 Liver Biomarker Score with the Severity of Heart Failure
by: Roxana Buzas, et al.
Published: (2024-11-01)

Experience of enrollment and management of the Waiting list for liver transplantation at hepatological center
by: Ye. N. Bessonova, et al.
Published: (2013-12-01)

The rate of liver impairment, character of bacteremia and serum bactericidal activity in patients with cirrhosis
by: Krutikov S.N., et al.
Published: (2014-06-01)

Survival of Patients with Alcohol-Related Liver Disease Cirrhosis—Usefulness of the New Liver Mortality Inpatients Prognostic Score
by: Vera Matovic Zaric, et al.
Published: (2024-11-01)

Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)
by: M.I. Tutchenko, et al.
Published: (2024-06-01)

Leading causes of fever in patients with liver function disorders
by: V. T. Ivashkin, et al.
Published: (2010-02-01)

IMPACT OF SARCOPENIA ON THE PROGNOSIS OF PATIENTS WITH CIRRHOSIS HOSPITALIZED FOR ACUTE DECOMPENSATION OR ACUTE-ON-CHRONIC LIVER FAILURE
by: Leticia Macedo EIFLER, et al.
Published: (2024-11-01)

Alcohol-induced liver disease: primary and secondary prevention
by: S. V. Plyusnin, et al.
Published: (2015-07-01)

MONOCYTE ADHESION MOLECULES EXPRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND LIVER CIRRHOSIS
by: Nora E.I. El-Bassiouni, et al.
Published: (2013-09-01)

Analysis of unsatisfactory results of laparoscopic cholecystectomy in patients with cirrhosis of the liver.
by: S. D. Khimich, et al.
Published: (2019-10-01)

Analysis of unsatisfactory results of laparoscopic cholecystectomy in patients with cirrhosis of the liver.
by: S. D. Khimich, et al.
Published: (2018-12-01)

CT and MR Imaging of Hepatocellular Carcinoma and Liver Cirrhosis
by: Masahiro Okada, et al.
Published: (2024-11-01)

Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer
by: Lulu Sun, et al.
Published: (2024-12-01)

Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment
by: Kazuo Tarao, et al.
Published: (2019-03-01)

The Relationship Between Chronic Liver Disease and Osteoporosis: A Retrospective Single-Center Experience
by: Sarah Abdulkarim Alnemari, et al.
Published: (2024-12-01)

Noninvasive Assessment of Liver Fibrosis by Magnetic Resonance Elastography in Patients with Rheumatic Disease on Long-Term Methotrexate Treatment
by: Arindam Nandy Roy, et al.
Published: (2023-01-01)

Nucleoside analogues in treatment of liver cirrhosis as an outcome of chronic hepatitis B
by: I. G. Bakulin
Published: (2009-02-01)

Structure of Patients with Hepatocellular Cancer (Data Analysis from Two Specialised Centres)
by: M. V. Mayevskaya, et al.
Published: (2020-05-01)

Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C
by: V. T. Ivashkin, et al.
Published: (2023-06-01)

Investigation of hemostasis by thromboelastography in the patient with liver cirrhosis (Clinical case)
by: Ye. L. Bulanova, et al.
Published: (2011-12-01)

Benefits of Liver Volume and Serum Zinc Level Assessment for the Screening of Covert Hepatic Encephalopathy in Patients with Child–Pugh Class A Cirrhosis
by: Masanori Fukushima, et al.
Published: (2024-12-01)

Predicting the Impact of Polysulfone Dialyzers and Binder Dialysate Flow Rate on Bilirubin Removal
by: Alexander Novokhodko, et al.
Published: (2024-12-01)

An Assessment of the Feasibility, Patient Acceptance, and Performance of Point-of-Care Transient Elastography for Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review and Meta-Analysis
by: Taranika Sarkar Das, et al.
Published: (2024-11-01)

Histologic evidence of neutrophil extracellular traps and fibrin(ogen) deposition in liver biopsies from patients with inflammatory liver disease
by: Fien A. von Meijenfeldt, et al.
Published: (2025-01-01)

COVID-19 Seroprevalence in Cirrhotic Patients and Effect of COVID-19 Infection on Liver Cirrhosis by Clinical Form in the Postinfectious Period
by: Uğur Önal, et al.
Published: (2024-11-01)